Colgate-Palmolive Company (NYSE:CL) Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 62.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,618 shares of the company's stock after selling 22,502 shares during the quarter. Kingsview Wealth Management LLC's holdings in Colgate-Palmolive were worth $1,276,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Personal CFO Solutions LLC acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $285,000. Aviva PLC grew its stake in Colgate-Palmolive by 13.4% in the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after acquiring an additional 114,855 shares during the last quarter. Vision Capital Management Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $322,000. Autumn Glory Partners LLC grew its stake in Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after acquiring an additional 3,586 shares during the last quarter. Finally, Financial Gravity Asset Management Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $2,166,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 2.3%

NYSE CL traded up $2.02 during mid-day trading on Tuesday, hitting $88.66. The company's stock had a trading volume of 5,046,613 shares, compared to its average volume of 4,865,534. Colgate-Palmolive Company has a 52-week low of $85.32 and a 52-week high of $109.30. The stock's fifty day simple moving average is $90.34 and its two-hundred day simple moving average is $90.38. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The firm has a market capitalization of $71.85 billion, a P/E ratio of 25.05, a price-to-earnings-growth ratio of 4.59 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter last year, the company earned $0.86 earnings per share. Colgate-Palmolive's revenue for the quarter was down 3.0% on a year-over-year basis. Research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's payout ratio is currently 58.76%.

Analysts Set New Price Targets

A number of brokerages recently commented on CL. Wall Street Zen cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Barclays upped their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $100.64.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.